CureDuchenne to Host SareptAssist Webinar on October 11 to Provide an Overview of Sarepta’s Patient Support Program for Duc...
October 06 2016 - 12:08PM
Business Wire
CureDuchenne, a nonprofit dedicated to funding research and
improving patient care for Duchenne muscular dystrophy, will host a
webinar with Sarepta Therapeutics, Inc. (NASDAQ: SRPT) on October
11 at 1 p.m. ET/10 a.m. PT to provide the Duchenne community an
overview of Sarepta’s patient support program, SareptAssist.
The webinar will address patient referrals, consideration for
starting therapy, case management process and financial assistance
programs. The webinar will be presented by Dan Madden, Director of
Patient Services, Sarepta Therapeutics, and moderated by Dr. Mike
Kelly, CureDuchenne’s Chief Scientific Officer. To learn more,
please visit www.SareptAssist.com.
Duchenne muscular dystrophy is a fatal genetic disease that
causes muscle degeneration and affects 1 in 3,500 boys. Boys with
Duchenne are usually diagnosed by age 5, lose their ability to walk
by age 12 and most don’t survive their mid-20s. CureDuchenne
provided early funding and support to Sarepta Therapeutics that
contributed to the development of eteplirsen.
To register for the webinar on October 11, click here. The call
in number is (844) 337-8088 and the conference ID number is
93592813.
About CureDuchenne
CureDuchenne was founded in 2003 with a focus
on saving the lives of those with Duchenne muscular dystrophy, a
disease that affects more than 300,000 children and young adults
worldwide. With support from CureDuchenne, nine research projects
have advanced to human clinical trials. CureDuchenne also brings
physical therapy and standard of care to local communities around
the country through its CureDuchenne Cares program. For more
information, please visit CureDuchenne.org and follow us on
Facebook, Twitter, Instagram and YouTube.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161006006100/en/
CureDuchenneKaren Harley, 949-872-2552
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024